CMS Policies Are Gutting U.S. Wound Care While Rewarding a Foreign Manufacturer
The Centers for Medicare & Medicaid Services (CMS) have created a health care crisis that’s threatening patients in dire need of care and decimating American made products, the best in the world.
THE REALITY
-
In a matter of weeks, there’s been more than an 80% decline in wound care volume as CMS’s Physician Fee Schedule (PFS) rule withholds and precludes coverage, and providers are forced to stop prescribing.
-
As a result, clinic closures and service cutbacks are leaving Several million patients unable to access state-of-the-art wound care.
-
As U.S. manufacturers are forced out of the market and providers cannot treat patients, an India-based manufacturer is offering its product at virtually no cost to providers.
-
The product was previously sold in the U.S. at an ASP of $4,227.97 per square centimeter and is now being offered for less than 0.3% of that amount, without any published clinical evidence of effectiveness, and imported from India.
-

THE REMEDY
-
CMS must expedite a coverage policy that ensures adequate reimbursement and market access for safe, clinically effective skin substitute products.
-
Journal of wound care, VOL 34, NO 10 (2025)
-

Paid for by Diabetic Wound Awareness PAC, PMB 411,1229 Chestnut Street Philadelphia, PA 19107. Not authorized by any candidate or candidate’s committee. Contributions to the Independent Expenditure Account of Diabetic Wound Awareness (DWA) PAC are not deductible as charitable contributions forfederal income tax purposes. Contributions from federal contractors and foreign nationals are prohibited. Federal Law requires Diabetic Wound Awareness (DAW) PAC to use best efforts to collect and report to the Federal Election Commission the name, mailing address, occupation and employer of each contributor, and any contributor needs to supply such information.


.jpg)